[Diagnosis and treatment of kala-azar].
作者信息
Neves J
出版信息
Rev Paul Med. 1983 Nov-Dec;101(6):237-9.
PMID:6677985
Abstract
摘要
相似文献
1
[Diagnosis and treatment of kala-azar].[黑热病的诊断与治疗]
Rev Paul Med. 1983 Nov-Dec;101(6):237-9.
2
Diagnosis and treatment of kala-azar.黑热病的诊断与治疗。
Indian Pediatr. 1994 Jun;31(6):741-8.
3
[Treatment of visceral leishmaniasis or kala-azar (author's transl)].内脏利什曼病或黑热病的治疗（作者译）
Med Trop (Mars). 1978 Jul-Aug;38(4):401-4.
4
Treatment of kala-azar in India.印度黑热病的治疗。
Natl Med J India. 1992 Sep-Oct;5(5):203-5.
5
Kala-azar in Afghanistan.阿富汗的黑热病
J Trop Med Hyg. 1982 Oct;85(5):201-4.
6
Treatment of kala azar.黑热病的治疗。
Lancet. 1996 Jun 15;347(9016):1701. doi: 10.1016/s0140-6736(96)91536-6.
7
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].[葡甲胺锑酸盐和葡萄糖酸锑钠治疗利什曼病。16例研究]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):607-10.
8
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
Arch Fr Pediatr. 1991 May;48(5):349-51.
9
Kala-azar--new developments in diagnosis and treatment.黑热病——诊断与治疗的新进展
Indian J Pediatr. 1999 Jan-Feb;66(1):63-71. doi: 10.1007/BF02752355.
10
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?儿童内脏利什曼病的治疗：两性霉素B还是五价锑化合物？
Int J Antimicrob Agents. 2005 Jan;25(1):26-30. doi: 10.1016/j.ijantimicag.2004.09.011.
引用本文的文献
1
Epidemiologic, clinical, diagnostic and therapeutic aspects of visceral leishmaniasis in renal transplant recipients: experience from thirty cases.肾移植受者内脏利什曼病的流行病学、临床、诊断和治疗方面：30 例经验。
BMC Infect Dis. 2015 Feb 25;15:96. doi: 10.1186/s12879-015-0852-9.
Zotero 插件